Revised Definitions of Tuberculosis Resistance and Treatment Outcomes, France, 2006–2019
Definitions of resistance in multidrug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XDR TB) have been updated. Pre–XDR TB, defined as MDR TB with additional resistance to fluoroquinolones, and XDR TB, with additional resistance to bedaquiline or linezolid, are freque...
Main Authors: | Yousra Kherabi, Mathilde Fréchet-Jachym, Christophe Rioux, Yazdan Yazdanpanah, Frédéric Méchaï, Valérie Pourcher, Jérôme Robert, Lorenzo Guglielmetti |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2022-09-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/28/9/22-0458_article |
Similar Items
-
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
by: Jay Achar, et al.
Published: (2017-10-01) -
Beijing Lineage of MDR Mycobacterium tuberculosis in Bulgaria, 2007–2011
by: Stefan Panaiotov, et al.
Published: (2014-11-01) -
Classifying new anti-tuberculosis drugs: rationale and future perspectives
by: Simon Tiberi, et al.
Published: (2017-03-01) -
Linezolid-Associated Neurologic Adverse Events in Patients with Multidrug-Resistant Tuberculosis, France
by: Marie Jaspard, et al.
Published: (2020-08-01) -
atpE Mutation in Mycobacterium tuberculosis Not Always Predictive of Bedaquiline Treatment Failure
by: Laure Fournier Le Ray, et al.
Published: (2022-05-01)